TBCD
Tubulin-specific chaperone D
Also known as: TBCD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BTW9
- Gene
- TBCD
- Ensembl
- ENSG00000141556
- Chromosome
- 17
- Canonical length
- 1192 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1192 residues, UniProt reviewed canonical sequence.
>Q9BTW9|TBCD
1 MALSDEPAAG GPEEEAEDET LAFGAALEAF GESAETRALL GRLREVHGGG AEREVALERF
61 RVIMDKYQEQ PHLLDPHLEW MMNLLLDIVQ DQTSPASLVH LAFKFLYIIT KVRGYKTFLR
121 LFPHEVADVE PVLDLVTIQN PKDHEAWETR YMLLLWLSVT CLIPFDFSRL DGNLLTQPGQ
181 ARMSIMDRIL QIAESYLIVS DKARDAAAVL VSRFITRPDV KQSKMAEFLD WSLCNLARSS
241 FQTMQGVITM DGTLQALAQI FKHGKREDCL PYAATVLRCL DGCRLPESNQ TLLRKLGVKL
301 VQRLGLTFLK PKVAAWRYQR GCRSLAANLQ LLTQGQSEQK PLILTEDDDE DDDVPEGVER
361 VIEQLLVGLK DKDTVVRWSA AKGIGRMAGR LPRALADDVV GSVLDCFSFQ ETDKAWHGGC
421 LALAELGRRG LLLPSRLVDV VAVILKALTY DEKRGACSVG TNVRDAACYV CWAFARAYEP
481 QELKPFVTAI SSALVIAAVF DRDINCRRAA SAAFQENVGR QGTFPHGIDI LTTADYFAVG
541 NRSNCFLVIS VFIAGFPEYT QPMIDHLVTM KISHWDGVIR ELAARALHNL AQQAPEFSAT
601 QVFPRLLSMT LSPDLHMRHG SILACAEVAY ALYKLAAQEN RPVTDHLDEQ AVQGLKQIHQ
661 QLYDRQLYRG LGGQLMRQAV CVLIEKLSLS KMPFRGDTVI DGWQWLINDT LRHLHLISSH
721 SRQQMKDAAV SALAALCSEY YMKEPGEADP AIQEELITQY LAELRNPEEM TRCGFSLALG
781 ALPGFLLKGR LQQVLTGLRA VTHTSPEDVS FAESRRDGLK AIARICQTVG VKAGAPDEAV
841 CGENVSQIYC ALLGCMDDYT TDSRGDVGTW VRKAAMTSLM DLTLLLARSQ PELIEAHTCE
901 RIMCCVAQQA SEKIDRFRAH AASVFLTLLH FDSPPIPHVP HRGELEKLFP RSDVASVNWS
961 APSQAFPRIT QLLGLPTYRY HVLLGLVVSL GGLTESTIRH STQSLFEYMK GIQSDPQALG
1021 SFSGTLLQIF EDNLLNERVS VPLLKTLDHV LTHGCFDIFT TEEDHPFAVK LLALCKKEIK
1081 NSKDIQKLLS GIAVFCEMVQ FPGDVRRQAL LQLCLLLCHR FPLIRKTTAS QVYETLLTYS
1141 DVVGADVLDE VVTVLSDTAW DAELAVVREQ RNRLCDLLGV PRPQLVPQPG ACLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TBCD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 57 nTPM
- thymus: 44 nTPM
- heart muscle: 35 nTPM
- thyroid gland: 34 nTPM
- spleen: 31 nTPM
- adipose tissue: 30 nTPM
Single-cell type
- thymocytes: 241 nCPM
- endometrial luminal cells: 197 nCPM
- oocytes: 170 nCPM
- somatotrophs: 157 nCPM
- vascular endothelial cells: 121 nCPM
- endometrial glandular cells: 112 nCPM
Immune cell
- non-classical monocyte: 51 nTPM
- intermediate monocyte: 41 nTPM
- MAIT T-cell: 28 nTPM
- memory CD8 T-cell: 24 nTPM
- gdT-cell: 23 nTPM
- basophil: 21 nTPM
Brain region
- choroid plexus: 52 nTPM
- hippocampal formation: 52 nTPM
- pons: 51 nTPM
- midbrain: 50 nTPM
- basal ganglia: 50 nTPM
- cerebral cortex: 48 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TBCD.
Disease | AllUniProt
Conditions TBCD is implicated in, by any mechanism.
- Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) MIM:617193
Disease | GeneticClinVar
94 pathogenic / likely-pathogenic of 1,436 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
- TBCD-related disorder
- Hepatocellular carcinoma
- Inborn genetic diseases
- Nonpapillary renal cell carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.82
- DepMap mean gene effect
- -1.2
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction assembly
- bicellular tight junction assembly
- cell morphogenesis involved in neuron differentiation
- microtubule cytoskeleton organization
- mitotic cell cycle
- negative regulation of cell-substrate adhesion
- negative regulation of microtubule polymerization
- post-chaperonin tubulin folding pathway
- protein folding
- tubulin complex assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-like helical
- Armadillo-type fold
- Tubulin-folding cofactor D, C-terminal domain
- Tubulin-folding cofactor D
- Tubulin-folding cofactor D, ARM repeats
- Tubulin folding cofactor D C terminal
- Tubulin-specific chaperone D-like, ARM repeat
- Tubulin-specific chaperone D-like, ARM repeats
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TBCD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TBCD as an antibody target. Whether an autoantibody or antibody against TBCD could matter depends on whether native TBCD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TBCD is annotated at the cell surface, where native TBCD is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TBCD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...